BriaCell Therapeutics Corp. (NASDAQ: BCTX, BCTXW) a clinical-stage biotech company that develops novel immunotherapies to transform cancer care, announced that the first patient was dosed in its Phase ...
Some results have been hidden because they may be inaccessible to you